Literature DB >> 24965234

Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency.

Naoya Nakagawa1, Yoshiaki Murakami, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Naru Kondo, Hayato Sasaki, Keisuke Okano, Taijiro Sueda.   

Abstract

BACKGROUND: In recent years, nonalcoholic fatty liver disease (NAFLD) after pancreatoduodenectomy (PD) has become increasingly problematic. Our aims were to clarify the relationship between NAFLD and postoperative pancreatic exocrine function and to identify the risk factors for NAFLD after PD.
METHODS: Patients who underwent PD (n = 104) were assessed with abdominal unenhanced computed tomography (CT) to determine the fatty liver changes and were given a (13) C-labeled mixed triglyceride breath test to measure pancreatic exocrine function. The percent (13) CO2 cumulative dose at 7 hr (% dose (13) C cum 7 hr) <5% was considered diagnostic for pancreatic exocrine insufficiency (PEI). Relationships between the occurrence of NAFLD and clinical factors including postoperative pancreatic exocrine function were analyzed.
RESULTS: Twenty-six of 104 patients (25%) developed postoperative NAFLD. The postoperative CT attenuation of the liver (R = 0.326, P < 0.001) and the liver-to-spleen attenuation ratio (R = 0.315, P = 0.001) significantly correlated with the postoperative values of % dose (13) C cum 7 hr. Multivariate analysis determined that postoperative PEI was the only independent risk factor for NAFLD (P = 0.025).
CONCLUSIONS: NAFLD frequently occurs postoperatively after PD. NAFLD after PD may be closely associated with postoperative PEI.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  13C-labeled mixed triglyceride breath test; computed tomography attenuation; nonalcoholic fatty liver disease; pancreatic exocrine insufficiency; pancreatoduodenectomy

Mesh:

Substances:

Year:  2014        PMID: 24965234     DOI: 10.1002/jso.23693

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Tokio Higaki; Masamichi Moriguchi; Nao Yoshida; Teruyuki Miyazaki; Yoichi Teshima
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

2.  Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm.

Authors:  Carrie Luu; Ram Thapa; Trevor Rose; Katherine Woo; Daniel Jeong; Kerry Thomas; Dung-Tsa Chen; Mark Friedman; Mokenge P Malafa; Pamela J Hodul
Journal:  Int J Surg       Date:  2018-09-12       Impact factor: 6.071

3.  Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer.

Authors:  Keita Kouzu; Hironori Tsujimoto; Makoto Nishikawa; Manabu Harada; Takao Sugihara; Hiromi Nagata; Shuichi Hiraki; Yoshihisa Yaguchi; Risa Takahata; Shinsuke Nomura; Nozomi Ito; Yusuke Ishibashi; Yujiro Itazaki; Satoshi Tsuchiya; Kazuo Hase; Yoji Kishi; Hideki Ueno
Journal:  Gastric Cancer       Date:  2019-09-25       Impact factor: 7.370

Review 4.  Pathophysiology after pancreaticoduodenectomy.

Authors:  Chang Moo Kang; Jin Ho Lee
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

5.  Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Kensuke Yamamura; Yo-Ichi Yamashita; Takanobu Yamao; Yuki Kitano; Kota Arima; Tatsunori Miyata; Takaaki Higashi; Hiromitsu Hayashi; Toru Beppu; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2022-02-12

6.  New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors.

Authors:  Tara Michella Mackay; Cansu Güney Genç; Robert Bart Takkenberg; Marc Gerard Besselink; Inne Somers; Elisabeth Jacqueline Maria Nieveen van Dijkum
Journal:  J Surg Oncol       Date:  2018-03-24       Impact factor: 3.454

7.  Perioperative Computed Tomography Assessments of the Pancreas Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy.

Authors:  Katsuhisa Ohgi; Yukiyasu Okamura; Yusuke Yamamoto; Ryo Ashida; Takaaki Ito; Teiichi Sugiura; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

8.  Identification of Nonalcoholic Fatty Liver Disease following Pancreatic Surgery in a Western Cohort Using a Novel Radiographic Technique.

Authors:  Sidney Olefson; Melissa Jackson; David J Grand; Kevin P Charpentier; Nirav Makwana; Kittichai Promrat
Journal:  J Clin Transl Hepatol       Date:  2015-12-15

9.  Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.

Authors:  Tadanobu Nagaya; Naoki Tanaka; Takefumi Kimura; Hiroyuki Kitabatake; Naoyuki Fujimori; Michiharu Komatsu; Akira Horiuchi; Takahiro Yamaura; Takeji Umemura; Kenji Sano; Frank J Gonzalez; Toshifumi Aoyama; Eiji Tanaka
Journal:  BBA Clin       Date:  2015-02-19

10.  Risk factors for development of nonalcoholic fatty liver disease after pancreatoduodenectomy.

Authors:  Yoshiro Fujii; Atsushi Nanashima; Masahide Hiyoshi; Naoya Imamura; Koichi Yano; Takeomi Hamada
Journal:  Ann Gastroenterol Surg       Date:  2017-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.